P-0242 Xelox and Bevacizumab as First-Line Treatment in fit Elderly Patients with Metastatic Colorectal Cancer: The Boxe Study

MLA

Giorgio Reggiardo, et al. “P-0242 Xelox and Bevacizumab as First-Line Treatment in Fit Elderly Patients with Metastatic Colorectal Cancer: The Boxe Study.” Annals of Oncology, vol. 23, June 2012, p. iv99. EBSCOhost, https://doi.org/10.1016/s0923-7534(20)30170-8.

APA

Giorgio Reggiardo, Gerardo Rosati, Alfredo Butera, Domenico Bilancia, Antonio Avallone, Federica De Pauli, & Giuseppe Aprile. (2012). P-0242 Xelox and Bevacizumab as First-Line Treatment in fit Elderly Patients with Metastatic Colorectal Cancer: The Boxe Study. Annals of Oncology, 23, iv99. https://doi.org/10.1016/s0923-7534(20)30170-8

Chicago

Giorgio Reggiardo, Gerardo Rosati, Alfredo Butera, Domenico Bilancia, Antonio Avallone, Federica De Pauli, and Giuseppe Aprile. 2012. “P-0242 Xelox and Bevacizumab as First-Line Treatment in Fit Elderly Patients with Metastatic Colorectal Cancer: The Boxe Study.” Annals of Oncology 23 (June): iv99. doi:10.1016/s0923-7534(20)30170-8.